Over seven million dogs in the United States alone have Mitral Valve Disease (MVD). For certain breeds, such as Cavalier King Charles Spaniels, more than 80% of dogs will be afflicted with MVD. We aim to change this.
We have developed a cardio-protective gene therapy that holds the promise of stopping the progression of MVD. We are preparing to run a pilot study in dogs with MVD.